Q4 2024 Pulmonx Corp Earnings Call Transcript
Key Points
- Pulmonx Corp (LUNG) reported a 23% increase in worldwide sales for Q4 2024, reaching $23.8 million, driven by strong US and international sales growth.
- The company added 52 new centers in the US in 2024, ending the year with 283 active accounts, indicating successful expansion of its US account base.
- Pulmonx Corp (LUNG) launched the Lung Tracks platform to streamline customer workflows and identify eligible patients, showing innovation in patient management.
- The company reported successful clinical trial results, with 77.6% of patients showing successful conversion of collateral ventilation status after treatment.
- Pulmonx Corp (LUNG) achieved a 22% growth in full-year 2024 worldwide revenue, reflecting substantial progress in commercial initiatives and market expansion.
- Despite strong revenue growth, Pulmonx Corp (LUNG) reported a net loss of $13.2 million for Q4 2024, indicating ongoing financial challenges.
- The company's gross margin for Q4 2024 was 74%, slightly down from 75% in the prior year period, suggesting pressure on profitability.
- Operating expenses increased by 9% in Q4 2024, driven by higher clinical expenses and commercial investments, impacting overall financial performance.
- Pulmonx Corp (LUNG) anticipates a negative impact of approximately 100 basis points on 2025 reported revenue due to foreign exchange fluctuations.
- The company expects 2025 revenue growth to be below its long-term target of 20%, with guidance set at 16-18% constant currency growth, indicating potential challenges in achieving its growth objectives.
Ladies and gentlemen, thank you for standing by. Welcome to lumin's 4th quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you would need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw the question, please press 11 again.
Please be advised that today's conference is being recorded. I would like now to turn the conference over to the first speaker today, Elizabeth Sparicio, investor relations. Please go ahead.
Good afternoon and thank you all for participating in today's call. Joining me from Pilmonox are Steve Williamson, President and Chief Executive Officer, and Meihuul Joshi, Chief Financial Officer. Earlier today, Pomonox issued a press release announcing its financial results for the quarter and year ended December 31, 2024. A copy of the press release is available on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
